Cite
HARVARD Citation
MacMillan, E. et al. (2019). Magnetic resonance spectroscopy evidence for declining gliosis in MS patients treated with ocrelizumab versus interferon beta-1a. Multiple sclerosis journal, experimental, translational and clinical. 5 (4), p. . [Online].